ETON
ETON
NASDAQ · Pharmaceuticals

Eton Pharmaceuticals Inc

$34.95
+0.97 (+2.85%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target -65.9% upside
Low Target $8.04
Average Target $11.93
High Target $13.91
Current Price $34.95
Current
$34.95
Target
$11.93
$8.04 $11.93 avg $13.91
Scenario Analysis
Bear Case
$8.04
-77.0%
Low target
Base Case
$11.93
-65.9%
Avg target
Bull Case
$13.91
+-60.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$35.66
-2.0% from high
52-Week Low
$13.09
+167.0% from low
Target vs 52W High
$11.93
-66.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%